Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Ni, Jie ^a   Ma, Xiaojing ^a   Zhou, Mi ^a   Pan, Xiaoping ^a   Tang, Junling ^a   Hao, Yaping ^a   Lu, Zhigang ^a   Gao, Meifang ^a   Bao, Yuqian ^a   Jia, Weiping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Atherosclerosis; Coronary artery disease; Metabolic syndrome; Serum LCN2 levels

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENZYME IMMUNOASSAY; FAMILY HISTORY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEUTROPHIL; OBESITY; PROTEIN BLOOD LEVEL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE-PHASE PROTEINS; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; COHORT STUDIES; CORONARY ARTERY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPOCALINS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTO-ONCOGENE PROTEINS; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES;

EID: 84890471085     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-176     Document Type: Article

References (34)

1. World Health Organization Global atlas on cardiovascular disease prevention and control 2011, Geneva: World Health Organization, World Health Organization.
2. Hutcheson R, Rocic P. The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration. Exp Diabetes Res 2012, 2012:271028. 3399393, 22829804.
3. Nijm J, Wikby A, Tompa A, Olsson AG, Jonasson L. Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. Am J Cardiol 2005, 95:452-456. 10.1016/j.amjcard.2004.10.009, 15695127.
4. Friedl A, Stoesz SP, Buckley P, Gould MN. Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues: cell type-specific pattern of expression. Histochem J 1999, 31:433-441. 10.1023/A:1003708808934, 10475571.
5. Wang Y, Lam KS, Kraegen EW, Sweeney G, Zhang J, Tso AW, Chow WS, Wat NM, Xu JY, Hoo RL, Xu A. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, hyperglycemia in humans. Clin Chem 2007, 53:34-41.
6. Yan QW, Yang Q, Mody N, Graham TE, Hsu CH, Xu Z, Houstis NE, Kahn BB, Rosen ED. The adipokine lipocalin-2 is regulated by obesity and promotes insulin resistance. Diabetes 2007, 56:2533-2540. 10.2337/db07-0007, 17639021.
7. Tong Z, Wu X, Kehrer JP. Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886. Biochem J 2003, 372:203-210. 10.1042/BJ20021696, 1223388, 12614196.
8. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott K, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, Barasch J. Endocytic delivery of lipocalin-siderophore iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005, 115:610-621. 548316, 15711640.
9. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Poniatowski B, Pawlak K, Dobrzycki S. NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine. Int J Cardiol 2008, 127:290-291. 10.1016/j.ijcard.2007.04.048, 17566573.
10. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993, 268:10425-10432.
11. Folkesson M, Kazi M, Zhu C, Silveira A, Hemdahl A, Hamsten A, Hedin U, Swedenborg J, Eriksson P. Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms. Thromb and Haemost 2007, 98:427-433.
12. Aigner F, Maier HT, Schwelberger HG, Wallnéfer EA, Amberger A, Obrist P, Berger T, Mak TW, Maglione M, Margreiter R, Schneeberger S, Troppmair J. Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. Am J Transplant 2007, 7:779-788. 10.1111/j.1600-6143.2006.01723.x, 17391123.
13. Hemdahl AL, Gabrielsen A, Zhu C, Eriksson P, Hedin U, Kastrup J, Thorén P, Hansson GK. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Tbromb Vasc Biol 2006, 26:136-142.
14. Huang Y, Yang Z, Ye Z, Li Q, Wen J, Tao X, Chen L, He M, Wang X, Lu B, Zhang Z, Zhang W, Qu S, Hu R. Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people. Cardiovasc Diabetol 2012, 11:11. 10.1186/1475-2840-11-11, 3295671, 22292925.
15. Wallenius V, Elias E, Bergstorm GM, Zetterberg H, Behre CJ. The lipocalins retinol-binding protein-4, lipocalin-2 and lipocalin-type prostaglandin D2-synthase correlate with markers of inflammatory activity, alcohol intake and blood lipids, but not with insulin sensitivity in metabolically healthy 58-year-old Swedish men. Exp Clin Endocrinol Diabetes 2011, 119:75-80. 10.1055/s-0030-1265212, 21104585.
16. Zografos T, Haliassos A, Korovesis S, Giazitzoglou E, Voridis E, Katritsis D. Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease. Am J Cardiol 2009, 104:917-920. 10.1016/j.amjcard.2009.05.023, 19766756.
17. Sahinarslan A, Kocaman SA, Bas D, Akyel A, Ercin U, Zengin O, Timurkaynak T. Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease. Coron Artery Dis 2011, 22:333-338. 10.1097/MCA.0b013e3283472a71, 21558855.
18. Choi KM, Lee JS, Kim EJ, Baik SH, Seo HS, Choi DS, Oh DJ, Park CG. Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease. Eur J Endocrinol 2008, 158:203-207. 10.1530/EJE-07-0633, 18230827.
19. Yang G, Fan L, Tan J, Qi G, Zhang Y, Samet JM, Taylor CE, Becker K, Xu J. Smoking in China: findings of the 1996 National Prevalence Survey. JAMA 1999, 282:1247-1253. 10.1001/jama.282.13.1247, 10517427.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
21. Levey A, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999, 130:461-470. 10.7326/0003-4819-130-6-199903160-00002, 10075613.
22. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi 2007, 35:390-419. (in Chinese), Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults.
23. Judkins MP. Percutaneous transfemoral selective coronary arteriography. Radiol Clin North Am 1968, 6:467-492.
24. Tatami R, Mabuchi H, Ueda K, Ueda R, Haba T, Kametani T, Ito S, Koizumi J, Ohta M, Miyamoto S, Nakayama A, Kanaya H, Oiwake H, Genda A, Takeda R. Intermediate-density lipoprotein and cholesterol rich very low density lipoprotein angiographically determined coronary artery disease. Circulation 1981, 64:1174-1184. 10.1161/01.CIR.64.6.1174, 7296792.
25. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002, 90:251-262.
26. Yah L, Borregaard N, Kjeldsen L, Moses MA. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). J Biol Chem 2001, 276:37258-37265. 10.1074/jbc.M106089200, 11486009.
27. Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclertic plaque rupture. Physiol Rev 2005, 85:1-31. 10.1152/physrev.00048.2003, 15618476.
28. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053. 10.2337/diacare.27.5.1047, 15111519.
29. Smith C, Damas JK, Otterdal K, Oie E, Sandberg WJ, Yndestad A, Waehre T, Scholz H, Endresen K, Olofsson PS, Halvorsen B, Gullestad L, Froland SS, Hansson GK, Aukrust P. Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation. J Am Coll Cardiol 2006, 48:1591-1599.
30. Paulsson J, Dadfar E, Held C, Jacobson SH, Lundahl J. Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease. Atherosclerosis 2007, 192:328-334. 10.1016/j.atherosclerosis.2006.08.003, 16963051.
31. Singh U, Devaraj S, Jialal I. C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes. Clin Chem 2009, 55:361-364. 2662851, 19074520.
32. Kobayashi S, Inoue N, Ohashi Y, Terashima M, Matsui K, Mori T, Fujita H, Awano K, Kobayashi K, Azumi H, Ejiri J, Hirata K, Kawashima S, Hayashi Y, Yokozaki H, Itoh H, Yokoyama M. Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler Thromb Vasc Biol 2003, 23:1398-1404. 10.1161/01.ATV.0000081637.36475.BC, 12805076.
33. Niu W, Qi Y. Matrix metalloproteinase family gene polymorphisms and risk for coronary artery disease: systematic review and meta-analysis. Heart 2012, 98:1483-1491. 10.1136/heartjnl-2012-302085, 22689717.
34. Solini A, Stea F, Santini E, Bruno RM, Duranti E, Taddei S, Ghiadoni L. Adipocytokine levels mark endothelial function in normotensive individuals. Cardiovasc Diabetol 2012, 11:103. 10.1186/1475-2840-11-103, 3502515, 22938533.